CAROL TALBOTT: Open Payments
NPI 1669123956 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 17 payments from 10 companies in 2025. Trend: 2023 $253 · 2024 $342 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $142 |
| AstraZeneca Pharmaceuticals LP | 2 | $128 |
| Novo Nordisk Inc | 3 | $62 |
| Dexcom, Inc. | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Amgen Inc. | 2 | $30 |
| ABBVIE INC. | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: BREZTRI, REXULTI, Ozempic, Dexcom G6 Transmitter, PREVNAR 20, VRAYLAR, ABILIFY MAINTENA, Rybelsus.
Industry payments across VA — which companies pay providers there.
